The invention provides novel substituted benzyl piperidine compounds according to Formula (I) as lysophosphatidic acid (LPA) receptor antagonists, their manufacture and use for the treatment of proliferative or inflammatory diseases, such as cancer, fibrosis or arthritis.
该发明提供了根据式(I)提供的新型取代
苄基哌啶化合物,作为赖
氨酸
磷脂酸(LPA)受体
拮抗剂,其制造和用于治疗增生性或炎症性疾病,如癌症、纤维化或关节炎。